Gene · 1128
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Care provided by midwives and the unmet needs of pregnant and postpartum women: A qualitative study of Japanese mothers. | Heliyon | 2023 | 37576280 | PubTator, text mining | PubMed |
| The Evaluation of Rac1 Signaling as a Potential Therapeutic Target of Alzheimer's Disease. | Int J Mol Sci | 2023 | 37569255 | PubTator, text mining | PubMed |
| Unveiling the Neural Environment in Cancer: Exploring the Role of Neural Circuit Players and Potential Therapeutic Strategies. | Cells | 2023 | 37566075 | PubTator, text mining | PubMed |
| Unraveling allostery within the angiotensin II type 1 receptor for Gαq and β-arrestin coupling. | Sci Signal | 2023 | 37552769 | PubTator, text mining | PubMed |
| Hepatic transcript profiling in beef cattle: Effects of rumen-protected niacin supplementation. | PLoS One | 2023 | 37535643 | PubTator, text mining | PubMed |
| Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-Emerging Human Monkeypox Virus. | J Microbiol Biotechnol | 2023 | 37519276 | PubTator, text mining | PubMed |
| Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes in Cannabis sativa. | Pharmaceutics | 2023 | 37514127 | PubTator, text mining | PubMed |
| Novel Hydrogel Membranes Based on the Bacterial Polysaccharide FucoPol: Design, Characterization and Biological Properties. | Pharmaceuticals (Basel) | 2023 | 37513903 | PubTator, text mining | PubMed |
| Discovering NDM-1 inhibitors using molecular substructure embeddings representations. | J Integr Bioinform | 2023 | 37498676 | PubTator, text mining | PubMed |
| A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs. | Nat Commun | 2023 | 37468498 | PubTator, text mining | PubMed |
| Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation. | Heliyon | 2023 | 37449101 | PubTator, text mining | PubMed |
| Outline of Salivary Gland Pathogenesis of Sjögren's Syndrome and Current Therapeutic Approaches. | Int J Mol Sci | 2023 | 37446355 | PubTator, text mining | PubMed |
| Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice. | Antiviral Res | 2023 | 37429529 | PubTator, text mining | PubMed |
| Dual effector population modification gene-drive strains of the African malaria mosquitoes, Anopheles gambiae and Anopheles coluzzii. | Proc Natl Acad Sci U S A | 2023 | 37428915 | PubTator, text mining | PubMed |
| Resistance training prescription for muscle strength and hypertrophy in healthy adults: a systematic review and Bayesian network meta-analysis. | Br J Sports Med | 2023 | 37414459 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| The landscape of cancer rewired GPCR signaling axes. | bioRxiv | 2023 | 37398064 | PubTator, text mining | PubMed |
| Improving Visual Working Memory with Cholinergic Deep Brain Stimulation. | Brain Sci | 2023 | 37371395 | PubTator, text mining | PubMed |
| Endoscopic Resection of Early Gastric Cancer and Pre-Malignant Gastric Lesions. | Cancers (Basel) | 2023 | 37370695 | PubTator, text mining | PubMed |
| Cymbopogon citratus Essential Oil: Extraction, GC-MS, Phytochemical Analysis, Antioxidant Activity, and In Silico Molecular Docking for Protein Targets Related to CNS. | Curr Issues Mol Biol | 2023 | 37367077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1128/papers?page=9